Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Clin Med (Lond) ; 22(2): 189-190, 2022 03.
Artículo en Inglés | MEDLINE | ID: covidwho-2145159
2.
J Travel Med ; 2022 Oct 09.
Artículo en Inglés | MEDLINE | ID: covidwho-2062929

RESUMEN

We identified and compared patients diagnosed with Plasmodium falciparum malaria at a large hospital in London, UK prior to the COVID-19 pandemic versus following relaxation of COVID-19-associated restrictions. We found that parasitaemias, rates of hyperpasitaemia and severe malaria were significantly higher in the period post-relaxation of COVID-19 restrictions.

3.
Clin Med (Lond) ; 22(5): 497, 2022 09.
Artículo en Inglés | MEDLINE | ID: covidwho-2056341
7.
J Clin Virol ; 148: 105083, 2022 03.
Artículo en Inglés | MEDLINE | ID: covidwho-1654709

RESUMEN

BACKGROUND: Transmission of hepatitis E virus (HEV) within the healthcare setting is extremely rare. Additionally, the development of chronic HEV infection in association with severe acute respiratory syndrome coronavirus disease 2 (SARS-CoV-2) infection and/or its immunomodulatory therapy has not been reported previously. AIMS: To describe the investigation and management of a nosocomial HEV transmission incident during the coronavirus disease 2019 (COVID-19) pandemic. METHODS: Epidemiological and molecular investigation of two individuals hospitalised with COVID-19 who were both diagnosed with HEV infection. RESULTS: Findings from our investigation were consistent with transmission of HEV from one patient with a community-acquired HEV infection to another individual (identical HEV sequences were identified in the two patients), most likely due to a breach in infection control practices whilst both patients shared a bed space on the intensive care unit (ICU). Chronic HEV infection requiring treatment with ribavirin developed in one patient with prolonged lymphopaenia attributable to COVID-19 and/or the immunomodulators received for its treatment. Further investigation did not identify transmission of HEV to any other patients or to healthcare workers. CONCLUSIONS: The extraordinary demands that the COVID-19 pandemic has placed on all aspects of healthcare, particularly within ICU settings, has greatly challenged the ability to consistently maintain optimal infection prevention and control practices. Under the significant pressures of the COVID-19 pandemic a highly unusual nosocomial HEV transmission incident occurred complicated further by progression to a chronic HEV infection in one patient.


Asunto(s)
COVID-19 , Infección Hospitalaria , Virus de la Hepatitis E , Hepatitis E , Infección Hospitalaria/epidemiología , Hepatitis E/tratamiento farmacológico , Hepatitis E/epidemiología , Virus de la Hepatitis E/genética , Humanos , Pandemias , Infección Persistente , SARS-CoV-2
8.
Clin Imaging ; 84: 36-37, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: covidwho-1654204
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA